NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--The European Patent Court in Munich, Germany has ruled in favor of Advaxis Incorporated (OTCBB: ADXS) and reversed a patent challenge made by Anza Therapeutics, Inc., formerly Cerus Corp (NASDAQ: CERS). The Court’s ruling is final and can not be appealed.
